FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206987822> ?p ?o ?g. }

• W4206987822 abstract "ETHER (Education THEérapeutique pour la Réduction des dommages en alcoologie or Therapeutic education for alcohol-related harm reduction) is a multicentre community-based mixed-methods study, which aims to evaluate the effectiveness of the innovative therapeutic patient education (TPE) programme 'Choizitaconso' in a sample of French people with alcohol use disorder (people with AUD). Choizitaconso teaches people with AUD psychosocial skills to help them (re)establish controlled drinking and reduce alcohol-related harms. Recruitment started in October 2019. We present here the protocol of the ETHER study.ETHER's quantitative component involves a 6-month controlled intervention study which evaluates Choizitaconso's effectiveness by comparing 30 people with AUD following the programme with a control group of 60 people with AUD not enrolled in it, using a questionnaire co-constructed by the research team and members of the people with AUD community. Thirty-four alcohol-related harms are assessed and summed to provide an individual measure of the 'harm burden' from consuming alcohol (primary outcome). Secondary outcomes are anticipated and internalized stigma, alcohol consumption measures, craving for alcohol, coping strategies, health-related quality of life, self-confidence to control or abstain from drinking, treatment self-regulation, anxiety and depressive symptoms, alcohol-related neuropsychological impairments, and capabilities (a measure of wellbeing in adults). Data will be collected in face-to-face and phone-based interviews at enrolment and 6 months later. Linear regression models will be used to assess the impact of the TPE programme on changes in the primary and secondary outcomes, while adjusting for other correlates and confounders. The study's qualitative component comprises semi-structured interviews with 16 people with AUD who have already completed the TPE programme at least 6 months before the interview. Qualitative interviews will be analysed using thematic analysis.ETHER is the first evaluation study of an innovative TPE programme specifically designed to reduce alcohol-related harms and reach controlled drinking in France. The involvement of the people with AUD community in selecting which experienced and perceived alcohol-related harms to measure ensures that ETHER will provide healthcare staff and researchers with a relevant set of harm reduction criteria for use in future research. Finally, ETHER will provide scientific justification for implementing novel alcohol-related harm reduction approaches and champion controlled drinking as a therapeutic goal. Trial registration ClinicalTrials.gov, NCT03954054. Registered 17 May 2019-Prospectively registered, https://clinicaltrials.gov/ct2/show/NCT03954054?cond=alcohol&cntry=FR&city=Marseille&draw=1&rank=1 ." @default.
• W4206987822 created "2022-01-26" @default.
• W4206987822 creator A5013548310 @default.
• W4206987822 creator A5018840232 @default.
• W4206987822 creator A5019026108 @default.
• W4206987822 creator A5038843087 @default.
• W4206987822 creator A5040074106 @default.
• W4206987822 creator A5045206498 @default.
• W4206987822 creator A5058525151 @default.
• W4206987822 creator A5069629924 @default.
• W4206987822 creator A5073519621 @default.
• W4206987822 creator A5073829911 @default.
• W4206987822 creator A5082455229 @default.
• W4206987822 creator A5084143254 @default.
• W4206987822 creator A5085208411 @default.
• W4206987822 creator A5086383411 @default.
• W4206987822 creator A5088141450 @default.
• W4206987822 date "2022-01-10" @default.
• W4206987822 modified "2023-09-30" @default.
• W4206987822 title "Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER)" @default.
• W4206987822 cites W1261242356 @default.
• W4206987822 cites W1839921965 @default.
• W4206987822 cites W1991157086 @default.
• W4206987822 cites W1997711531 @default.
• W4206987822 cites W2004824907 @default.
• W4206987822 cites W2006893169 @default.
• W4206987822 cites W2011644590 @default.
• W4206987822 cites W2024961803 @default.
• W4206987822 cites W2028726882 @default.
• W4206987822 cites W2030330723 @default.
• W4206987822 cites W2063425068 @default.
• W4206987822 cites W2066951696 @default.
• W4206987822 cites W2094311640 @default.
• W4206987822 cites W2114192637 @default.
• W4206987822 cites W2125230596 @default.
• W4206987822 cites W2142277224 @default.
• W4206987822 cites W2142976740 @default.
• W4206987822 cites W2156806379 @default.
• W4206987822 cites W2160313238 @default.
• W4206987822 cites W2160638424 @default.
• W4206987822 cites W2166281097 @default.
• W4206987822 cites W2172036914 @default.
• W4206987822 cites W2285153319 @default.
• W4206987822 cites W2344526152 @default.
• W4206987822 cites W2461644430 @default.
• W4206987822 cites W2522557458 @default.
• W4206987822 cites W2529503950 @default.
• W4206987822 cites W2793862337 @default.
• W4206987822 cites W2796000362 @default.
• W4206987822 cites W2887085557 @default.
• W4206987822 cites W2889166105 @default.
• W4206987822 cites W2898948647 @default.
• W4206987822 cites W2920129527 @default.
• W4206987822 cites W2946074218 @default.
• W4206987822 cites W2973687702 @default.
• W4206987822 cites W3029845652 @default.
• W4206987822 cites W3105843358 @default.
• W4206987822 cites W3120313884 @default.
• W4206987822 cites W4200584065 @default.
• W4206987822 cites W4241804385 @default.
• W4206987822 cites W4247448081 @default.
• W4206987822 doi "https://doi.org/10.1186/s12954-021-00587-0" @default.
• W4206987822 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35012570" @default.
• W4206987822 hasPublicationYear "2022" @default.
• W4206987822 type Work @default.
• W4206987822 citedByCount "3" @default.
• W4206987822 countsByYear W42069878222022 @default.
• W4206987822 countsByYear W42069878222023 @default.
• W4206987822 crossrefType "journal-article" @default.
• W4206987822 hasAuthorship W4206987822A5013548310 @default.
• W4206987822 hasAuthorship W4206987822A5018840232 @default.
• W4206987822 hasAuthorship W4206987822A5019026108 @default.
• W4206987822 hasAuthorship W4206987822A5038843087 @default.
• W4206987822 hasAuthorship W4206987822A5040074106 @default.
• W4206987822 hasAuthorship W4206987822A5045206498 @default.
• W4206987822 hasAuthorship W4206987822A5058525151 @default.
• W4206987822 hasAuthorship W4206987822A5069629924 @default.
• W4206987822 hasAuthorship W4206987822A5073519621 @default.
• W4206987822 hasAuthorship W4206987822A5073829911 @default.
• W4206987822 hasAuthorship W4206987822A5082455229 @default.
• W4206987822 hasAuthorship W4206987822A5084143254 @default.
• W4206987822 hasAuthorship W4206987822A5085208411 @default.
• W4206987822 hasAuthorship W4206987822A5086383411 @default.
• W4206987822 hasAuthorship W4206987822A5088141450 @default.
• W4206987822 hasBestOaLocation W42069878221 @default.
• W4206987822 hasConcept C118552586 @default.
• W4206987822 hasConcept C150966472 @default.
• W4206987822 hasConcept C15744967 @default.
• W4206987822 hasConcept C185592680 @default.
• W4206987822 hasConcept C2779442783 @default.
• W4206987822 hasConcept C2779541405 @default.
• W4206987822 hasConcept C2781066024 @default.
• W4206987822 hasConcept C48856860 @default.
• W4206987822 hasConcept C55493867 @default.
• W4206987822 hasConcept C70410870 @default.
• W4206987822 hasConcept C71924100 @default.
• W4206987822 hasConcept C73282008 @default.
• W4206987822 hasConceptScore W4206987822C118552586 @default.
• W4206987822 hasConceptScore W4206987822C150966472 @default.
• W4206987822 hasConceptScore W4206987822C15744967 @default.

• next